Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076750 · ClinicalTrials.gov registry record · Phase 1
Weekly Vitamin D in Pediatric IBD
A Phase 1 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT02076750 is a Phase 1 study that has completed, run by Emory University. The registered enrollment target is 34 participants.
The verdict
NCT02076750, a Phase 1 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether weekly dosing of oral vitamin D3 is effective in correcting low vitamin D levels in children and adolescents with inflammatory bowel disease (also known as Crohn's disease and ulcerative colitis).
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 (cholecalciferol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02076750
The ClinicalTrials.gov registry entry for NCT02076750 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D3 (cholecalciferol) is the first listed.
NCT02076750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02076750 about?
NCT02076750 is a clinical study titled "Weekly Vitamin D in Pediatric IBD". The purpose of this study is to determine whether weekly dosing of oral vitamin D3 is effective in correcting low vitamin D levels in children and adolescents with inflammatory bowel disease (also known as Crohn's disease and ulcerative colitis).
What is the current status of trial NCT02076750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2013-03. Estimated completion is 2014-06.
What interventions are being tested in trial NCT02076750?
The interventions under investigation include: Vitamin D3 (cholecalciferol) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02076750?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.